Longwood Healthcare Leaders Spring MIT to Convene Life Science Thought Leaders at MIT Koch Institute

BOSTON, MA / ACCESSWIRE / May 23, 2024 / Longwood Fund, an early-stage life science venture firm, will convene top biopharmaceutical leaders for two days of discussion and networking at its annual Longwood Healthcare Leaders Spring MIT forum. Co-hosted by Koch Institute Professors Phil Sharp and Bob Langer, the event will be held at MIT's Koch Institute on June 17-18, 2024.

The industry-leading meeting will focus on a wide range of topics affecting the biopharma ecosystem. Decision-makers in the life sciences, including biopharma CEOs, research and development heads, leading academics, and investors, will discuss critical issues in healthcare today.

Speakers at the forum include prominent figures such as Sally Kornbluth (President, MIT), Phil Sharp (Co-Founder, Alnylam, Biogen), Bob Langer (Co-Founder, Moderna), and many others. They will engage in curated fireside chats and discussion panels aimed at fostering open dialogue and actionable takeaways.

The agenda includes discussions on early-stage innovation, R&D collaboration, next-generation therapeutics, drug discovery, biopharma pipeline sourcing, licensing, and regulatory approval. Networking opportunities such as luncheons and a cocktail reception will facilitate further connections.

For more information, visit: www.longwoodhealthcareleaders.com/spring2024